Molecular Targets to Enhance the Radiation Effect and Overcome Radiation Resistance in Cancer

Dear colleagues

This Special Issue on "Molecular Targets to Enhance the Radiation Effect and Overcome Radiation Resistance in Cancer" will focus on radiation resistance and overcoming it via molecular targeting as well as enhancing the radiation effect through pharmacological molecular interventions. Moreover, the synergistic effects of radiation and immunotherapy and the timing of radiation related to immunotherapy will be addressed. The interaction between novel molecular targets and radiation is also of significant relevance. The abscopal effect and the biology related to this phenomenon, post-radiation molecular changes, and radioligand therapy are currently large areas of interest in overcoming radioresistance and enhancing radiotherapeutic effects, where sub-areas in these fields have not been fully elucidated. With radiation therapy being a cornerstone of anticancer therapy, optimizing and enhancing therapeutic outcomes is vital, and progress in this area will serve a critical unmet need.

Prof. Dr. Amichay Meirovitz
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• radioresistance
• radiosensitivity
• radiotherapy
• targeted therapy
• radioligand
• immunotherapy